➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Colorcon
Baxter
Boehringer Ingelheim
Merck

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

CEFAZOLIN SODIUM Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Cefazolin Sodium patents expire, and what generic alternatives are available?

Cefazolin Sodium is a drug marketed by Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Glaxosmithkline, Hikma Farmaceutica, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, and West-ward Pharms Int. and is included in thirty-two NDAs.

The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Cefazolin Sodium

A generic version of CEFAZOLIN SODIUM was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Start Trial

Drug patent expirations by year for CEFAZOLIN SODIUM
Recent Clinical Trials for CEFAZOLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of British ColumbiaEarly Phase 1
Aswan University HospitalN/A
Federal University of São PauloPhase 4

See all CEFAZOLIN SODIUM clinical trials

Pharmacology for CEFAZOLIN SODIUM
Medical Subject Heading (MeSH) Categories for CEFAZOLIN SODIUM

US Patents and Regulatory Information for CEFAZOLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065247-001 Aug 12, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 064170-002 Mar 18, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062831-003 Sep 25, 1992 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Colorcon
Baxter
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.